Shares in the company are trading at 52.5 cents, a premium to the 50-cent offer price.
Showing 25 of 284
Shareholders can acquire shares at 50 cents, being a discount to the last price of 56.5 cents.
This purchase follows recent buying from the company’s board’s chairman.
The company deemed a trading halt necessary due to time differences with Canada.
The dealer licence which was previously under the narcotic control regulations of the controlled drugs and substances act, has now been changed to the recently enacted cannabis act and cannabis regulations.
In the near term the company will continue its focus on the production of medicinal cannabis at its existing southern and northern facilities in Melbourne for supply to Australian patients.
The installation represents the company’s third agricultural sale to Dagan and follows substantial orders $323,000 and $278,000 respectively.
This follows chairman Geoff Starr’s on-market share purchases last month.
The GFS solution provides storage and distribution capabilities to automate and streamline the Polaris facility’s nutrient lifecycle planning.
Australian-based YPB Group said Namaste will apply its authenticity product markers to all products on Namaste's e-commerce platforms
80,000 shares at a cost of $10,193 represents a 12.7 cents per share average cost price.
The company expects to supply medicinal cannabis to patients from around March 2019.
The company has finalised negotiations with California-based company VaporSpec.
The company has purchased the property for $2.6 million in the Northern Rivers district of NSW.
Quentin Megson will serve jointly in the role with existing company secretary Susan Hunter.
The Root Zone Temperature Optimisation (RZTO) technology stabilises plant root zone temperatures, optimising plant physiology.
The halt will remain in place until the start of trading on Friday or when an announcement is released.
The new name reflects strategic developments in the company’s global medicinal cannabis business.
Non-executive director Max Johnston now holds 200,000 shares in an indirect interest.
CannaHub is a new addition to the MGC projects currently underway with the Royal Melbourne Institute of Technology, and will be formally launched in Q1 2019.
The company is working to raise awareness of its products among mainstream doctors and aims to reach 1,000 patients by this time next year.
The low-cost heating and cooling system warms roots during winter and cools them in summer.
The halt will remain until the start of trading on November 5 or when an announcement is released.
The Sydney-based investor has demonstrated confidence in the company’s medical research strategy.
The company is well-positioned to benefit from the ongoing sale of its cannabis oils to patients through approved prescribers.